adminの記事一覧

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.

Clin Exp Nephrol. 19(6): 1044-1053, 2015.PubMed

Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Diabetologia. 58(1): 188-198, 2015.PubMed

Pediatric reference ranges for acute kidney injury biomarkers.

Pediatr Nephrol. 30(4): 677-685, 2015.PubMed

LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: a retrospective analysis.

Diabetes Res Clin Pract. 106(2): 241-246, 2014.PubMed

NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.

Clin Chem Lab Med. 52(4): 537-546, 2014.PubMed

Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.

Am J Physiol Renal Physiol. 308(2): F114-121, 2014.PubMed

Early prediction of acute kidney injury biomarkers after endovascular stent graft repair of aortic aneurysm: a prospective observational study.

J Intensive Care. 2(45), 2014.PubMed

Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 20(12): 2010-2014, 2014.PubMed

A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.

J Infect Chemother. 21(3): 165-169, 2014.PubMed

Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women’s Interagency HIV Study (WIHS).

HIV Med. 15(5): 291-300, 2014.PubMed